News
In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G ...
Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...
Q1 2025 Earnings Conference Call April 29, 2025 8:00 AM ETCompany ParticipantsSloan Simpson - Head of Investor ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
The Elton John AIDS Foundation is delighted to announce the appointment of three new members to its Board of Directors - Tobias Hestler, Henry R. Muñoz III, and Joshua Schulman ? who bring a wealth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results